HomeELEV • NASDAQ
add
Elevation Oncology Inc
Previous close
$3.82
Day range
$3.69 - $4.13
Year range
$0.36 - $5.89
Market cap
202.16M USD
Avg Volume
969.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
1.26%
1.00%
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.87M | -15.20% |
Net income | -10.71M | 37.24% |
Net profit margin | — | — |
Earnings per share | -0.21 | 64.09% |
EBITDA | -9.86M | 15.21% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 104.05M | 40.74% |
Total assets | 108.96M | 41.70% |
Total liabilities | 33.14M | -23.16% |
Total equity | 75.82M | — |
Shares outstanding | 54.64M | — |
Price to book | 2.60 | — |
Return on assets | -24.91% | — |
Return on capital | -25.76% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.71M | 37.24% |
Cash from operations | -9.58M | 43.11% |
Cash from investing | 20.70M | -22.18% |
Cash from financing | 30.25M | 13,904.63% |
Net change in cash | 41.38M | 314.37% |
Free cash flow | -6.95M | 3.05% |
About
Founded
2019
Headquarters
Website
Employees
29